{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:49:46Z","timestamp":1791413386038,"version":"4.3.3"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR002537"],"award-info":[{"award-number":["UL1TR002537"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["annemergmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Emergency Medicine"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.annemergmed.2026.08.001","type":"journal-article","created":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T03:52:06Z","timestamp":1791345126000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["DO Generations MAtter for Treatment of Outpatient Pyelonephritis With Cephalosporins in the Emergency Department? DOGMA-ED Study"],"prefix":"10.1016","author":[{"given":"Alicia E.","family":"Mattson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devin","family":"Spolsdoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlin S.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Avram","family":"Fletcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spencer","family":"Laehn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lance","family":"Ray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyssa B.","family":"Polotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giles W.","family":"Slocum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruben","family":"Santiago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Krenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Zimmerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan A.","family":"Woolum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin T.","family":"Howington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preeyaporn","family":"Sarangarm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Zepeski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Briana","family":"Negaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Koehl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan A.","family":"Rech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Talan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5759-9857","authenticated-orcid":false,"given":"Brett","family":"Faine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.annemergmed.2026.08.001_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.idc.2013.09.003","article-title":"Urinary tract infection syndromes: occurrence, recurrence, bacteriology, risk factors, and disease burden","volume":"28","author":"Foxman","year":"2014","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.annemergmed.2026.08.001_bib2","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nrurol.2010.190","article-title":"The epidemiology of urinary tract infection","volume":"7","author":"Foxman","year":"2010","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.annemergmed.2026.08.001_bib3","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1093\/cid\/civ076","article-title":"US outpatient antibiotic prescribing variation according to geography, patient population, and provider specialty in 2011","volume":"60","author":"Hicks","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.annemergmed.2026.08.001_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0194085","article-title":"Predicting urinary tract infections in the emergency department with machine learning","volume":"13","author":"Taylor","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.annemergmed.2026.08.001_bib5","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.annemergmed.2012.09.002","article-title":"A call to action for antimicrobial stewardship in the emergency department: approaches and strategies","volume":"62","author":"May","year":"2013","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.annemergmed.2026.08.001_bib6","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.emc.2018.06.003","article-title":"The emergency department diagnosis and management of urinary tract infection","volume":"36","author":"Long","year":"2018","journal-title":"Emerg Med Clin North Am"},{"key":"10.1016\/j.annemergmed.2026.08.001_bib7","doi-asserted-by":"crossref","first-page":"i24","DOI":"10.1093\/cid\/ciaf459","article-title":"Clinical Practice Guideline by Infectious Diseases Society of America (IDSA): 2025 guideline on management and treatment of complicated urinary tract infections: introduction and methods","volume":"82","author":"Trautner","year":"2026","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.annemergmed.2026.08.001_bib8","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1111\/acem.14545","article-title":"High prevalence of fluoroquinolone-resistant UTI among US emergency department patients diagnosed with urinary tract infection, 2018-2020","volume":"29","author":"Faine","year":"2022","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.annemergmed.2026.08.001_bib9","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.3201\/eid2209.160148","article-title":"Fluoroquinolone-resistant and extended-spectrum \u03b2-lactamase-producing Escherichia coli infections in patients with pyelonephritis, United States","volume":"22","author":"Talan","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.annemergmed.2026.08.001_bib10","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ijid.2022.03.052","article-title":"Regional differences in antibiotic-resistant Enterobacterales urine isolates in the United States: 2018-2020","volume":"119","author":"Aronin","year":"2022","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.annemergmed.2026.08.001_bib11","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.44495","article-title":"Guidelines for the prevention, diagnosis, and management of urinary tract infections in pediatrics and adults: a WikiGuidelines Group Consensus Statement","volume":"7","author":"Nelson","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.annemergmed.2026.08.001_bib12","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.1093\/cid\/ciq257","article-title":"International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 Update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases","volume":"52","author":"Gupta","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.annemergmed.2026.08.001_bib13","doi-asserted-by":"crossref","first-page":"i36","DOI":"10.1093\/cid\/ciaf460","article-title":"Clinical practice guideline by Infectious Diseases Society of America (IDSA): 2025 guideline on management and treatment of complicated urinary tract infections: selection of antibiotic therapy for complicated UTI","volume":"82","author":"Trautner","year":"2026","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.annemergmed.2026.08.001_bib14","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.annemergmed.2024.10.013","article-title":"Cephalosporins for outpatient pyelonephritis in the emergency department: COPY-ED study","volume":"85","author":"Koehl","year":"2025","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.annemergmed.2026.08.001_bib15","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.ajem.2020.09.061","article-title":"Antibiotic prescribing patterns for adult urinary tract infections within emergency department and urgent care settings","volume":"45","author":"Maddali","year":"2021","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.annemergmed.2026.08.001_bib16","doi-asserted-by":"crossref","DOI":"10.1017\/ash.2023.435","article-title":"Outcomes of high-dose oral beta-lactam definitive therapy compared to fluoroquinolone or trimethoprim-sulfamethoxazole oral therapy for bacteremia secondary to a urinary tract infection","volume":"3","author":"Geyer","year":"2023","journal-title":"Antimicrob Steward Healthc Epidemiol"},{"key":"10.1016\/j.annemergmed.2026.08.001_bib17","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofaf435","article-title":"Navigating the muddled middle: a case-based exploration of oral \u03b2-lactams for systemic gram-negative infections","volume":"12","author":"Shif","year":"2025","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.annemergmed.2026.08.001_bib18","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1093\/clinids\/24.3.457","article-title":"Oral administration of antibiotics: a rational alternative to the parenteral route","volume":"24","author":"MacGregor","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.annemergmed.2026.08.001_bib19","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/s10049-008-1057-1","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting of observational studies","volume":"11","author":"Von Elm","year":"2008","journal-title":"Notf Rettungsmedizin"},{"key":"10.1016\/j.annemergmed.2026.08.001_bib20","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.idc.2007.10.002","article-title":"Urinary tract infections in the emergency department","volume":"22","author":"Abrahamian","year":"2008","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.annemergmed.2026.08.001_bib21","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.jsps.2018.02.023","article-title":"Risk factors for aquiring multidrug-resistant organisms in urinary tract infections: a systematic literature review","volume":"26","author":"Tenney","year":"2018","journal-title":"Saudi Pharm J"},{"key":"10.1016\/j.annemergmed.2026.08.001_bib22","series-title":"Complicated Urinary Tract Infections: Developing Drugs for Treatment","year":"2020"},{"key":"10.1016\/j.annemergmed.2026.08.001_bib23","series-title":"CLSI. Performance Standards for Antimicrobial Susceptibility Testing. 34th ed. CLSI supplement M100","year":"2024"},{"key":"10.1016\/j.annemergmed.2026.08.001_bib24","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1128\/JCM.00481-17","article-title":"Emergency department urinary antibiograms differ by specific patient group","volume":"55","author":"Jorgensen","year":"2017","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.annemergmed.2026.08.001_bib25","series-title":"Fluoroquinolone Antimicrobial Drugs Information","year":"2026"},{"key":"10.1016\/j.annemergmed.2026.08.001_bib26","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S1473-3099(18)30676-5","article-title":"Association between urinary community-acquired fluoroquinolone-resistant Escherichia coli and neighbourhood antibiotic consumption: a population-based case-control study","volume":"19","author":"Low","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.annemergmed.2026.08.001_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2022.106560","article-title":"Comparing outcomes among outpatients treated for pyelonephritis with oral cephalosporins versus first-line agents","volume":"59","author":"Fosse","year":"2022","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.annemergmed.2026.08.001_bib28","article-title":"A retrospective review of oral cephalosporins versus fluoroquinolones for the treatment of pyelonephritis","volume":"17","author":"Lin","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.annemergmed.2026.08.001_bib29","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1016\/j.ajem.2018.08.016","article-title":"Pyelonephritis treatment in the community emergency department: cephalosporins vs. first-line agents","volume":"36","author":"Vogler","year":"2018","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.annemergmed.2026.08.001_bib30","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofae193","article-title":"Real-world effectiveness of intravenous and oral antibiotic stepdown strategies for gram-negative complicated urinary tract infection with bacteremia","volume":"11","author":"Veillette","year":"2024","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.annemergmed.2026.08.001_bib31","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofad657","article-title":"Oral \u03b2-lactams, fluoroquinolones, or trimethoprim-sulfamethoxazole for definitive treatment of uncomplicated Escherichia coli or Klebsiella species bacteremia from a urinary tract source","volume":"11","author":"Alzaidi","year":"2024","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.annemergmed.2026.08.001_bib32","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.cmi.2022.10.004","article-title":"Highly versus less bioavailable oral antibiotics in the treatment of gram-negative bloodstream infections: a propensity-matched cohort analysis","volume":"29","author":"Mponponsuo","year":"2023","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.annemergmed.2026.08.001_bib33","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.20166","article-title":"Oral \u03b2-lactam antibiotics vs fluoroquinolones or trimethoprim-sulfamethoxazole for definitive treatment of Enterobacterales bacteremia from a urine source","volume":"3","author":"Sutton","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.annemergmed.2026.08.001_bib34","doi-asserted-by":"crossref","DOI":"10.1002\/phar.70118","article-title":"Oral \u03b2-lactams for complicated urinary tract infections: a systematic review and point-counterpoint comparison with trimethoprim\/sulfamethoxazole and fluoroquinolones","volume":"46","author":"Kunz Coyne","year":"2026","journal-title":"Pharmacother J Hum Pharmacol Drug Ther"},{"key":"10.1016\/j.annemergmed.2026.08.001_bib35","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/S0149-2918(00)80054-5","article-title":"Cefdinir versus cefaclor in the treatment of uncomplicated urinary tract infection","volume":"22","author":"Leigh","year":"2000","journal-title":"Clin Ther"},{"key":"10.1016\/j.annemergmed.2026.08.001_bib36","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s40360-023-00710-w","article-title":"Antibiotics and antibiotic-associated diarrhea: a real-world disproportionality study of the FDA adverse event reporting system from 2004 to 2022","volume":"24","author":"Huang","year":"2023","journal-title":"BMC Pharmacol Toxicol"},{"key":"10.1016\/j.annemergmed.2026.08.001_bib37","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.jaci.2014.07.062","article-title":"Adverse reactions associated with oral and parenteral use of cephalosporins: A retrospective population-based analysis","volume":"135","author":"Macy","year":"2015","journal-title":"J Allergy Clin Immunol"}],"container-title":["Annals of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196064426005469?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196064426005469?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:04:04Z","timestamp":1791410644000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196064426005469"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":37,"alternative-id":["S0196064426005469"],"URL":"https:\/\/doi.org\/10.1016\/j.annemergmed.2026.08.001","relation":{},"ISSN":["0196-0644"],"issn-type":[{"value":"0196-0644","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"DO Generations MAtter for Treatment of Outpatient Pyelonephritis With Cephalosporins in the Emergency Department? DOGMA-ED Study","name":"articletitle","label":"Article Title"},{"value":"Annals of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annemergmed.2026.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 by the American College of Emergency Physicians.","name":"copyright","label":"Copyright"}]}}